Advertisement
Life Science
Subscribe to Life Science

The Lead

Chikungunya Virus Shuts Down Infected Cells

December 17, 2014 4:59 pm | by Wageningen University | News | Comments

Researchers from Wageningen University, part of Wageningen UR, in collaboration with colleagues from Leiden University and a research team in Australia, have revealed how chikungunya virus blocks essential processes in infected cells that normally would keep the virus under control. Read more...

Stem Cell Prompting Deadly Fibrosis Found

December 17, 2014 4:35 pm | by Cynthia Fox, Science Writer | Articles | Comments

Some 45% of deaths are...

Study: Removing Clot Helps Limit Stroke Disability

December 17, 2014 2:25 pm | by Marilynn Marchione - AP Chief Medical Writer | News | Comments

A new treatment has been shown to limit the damage from a common type of stroke. Read more...

Rio Organizers Create 'Super Bacteria' Task Force

December 17, 2014 2:12 pm | by Jenny Barchfield - Associated Press | News | Comments

Brazilian organizers of the 2016 Olympics are creating a task force to deal with a so-called "...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Napster Co-Founder Makes Investment in Allergy Research

December 17, 2014 2:03 pm | by Olga R. Rodriguez - Associated Press | News | Comments

The former Facebook president said he wants to help find a lasting cure to allergies. Read more...                           

Emerging Markets Gain New Prominence as Innovation, Development Hotspots

December 17, 2014 12:52 pm | by Roger Humphrey, Executive Managing Director, Life Sciences Americas, JLL | Articles | Comments

Patent origin location has become the latest way patent applications can inform business strategy, and recent analysis shows where innovation hubs are on the rise. The United States and Europe have enjoyed long deep-seated roots as the leaders of high-value aspects of the biopharmaceutical development cycle, such as new product research and development (R&D). Read more...

New Insight Into How Motor Neurons in Brain Die During ALS

December 17, 2014 12:33 pm | News | Comments

Researchers look to understand the causes of amyotrophic lateral sclerosis (ALS), in the hope of finding new ways to treat the disease. A new study published online in the Cell Press journal Neuron shows that a common gene mutation in ALS generates a deadly protein that may cause the damage in the brain that leads to ALS. Read more...

Advertisement

Predicting Antibiotic Resistance

December 17, 2014 10:14 am | News | Comments

Treating bacterial infections with antibiotics is becoming increasingly difficult as bacteria develop resistance to the antibiotics being used against them. Read more...                

Clementia Launches First Natural History Study of Patients with FOP

December 17, 2014 10:04 am | News | Comments

Clementia Pharmaceuticals announced the initiation of a natural history study in patients with fibrodysplasia ossificans progressiva. Read more...                   

House Searches for Ebola in Sierra Leone Capital

December 17, 2014 9:25 am | by Clarence Roy-Macaulay - Associated Press | News | Comments

Surveillance teams fanned out Wednesday in Sierra Leone's capital to search every house for sick people. Read more...                        

14 Charged in Deadly 2012 Meningitis Outbreak

December 17, 2014 9:06 am | by Denise Lavoie - Associated Press | News | Comments

14 former owners or employees of a Massachusetts pharmacy were charged Wednesday in connection with a 2012 meningitis outbreak that killed 64 people. Read more...                 

Massachusetts Doctor Cured of Ebola Returning to Liberia

December 16, 2014 3:17 pm | by Philip Marcelo - Associated Press | News | Comments

A Massachusetts doctor cured of Ebola said Tuesday that he's returning to Liberia. Read more...                            

Advertisement

Hep C: The Fight for a Fair Drug Price

December 16, 2014 2:38 pm | by Ryan Bushey, Associate Editor | Articles | Comments

The price of one pill has placed Gilead Sciences in the middle of a lawsuit. Read more...                             

Altered White-Blood-Cell Motion in Burn Patients May Warn of Infection

December 16, 2014 11:54 am | by Harvard Medical School | News | Comments

A team of Harvard Medical School investigators at Massachusetts General Hospital has identified what may be a biomarker predicting the development of sepsis, a dangerous systemic infection in patients with serious burns. Read more..                          

'Super Bacteria' Found in Rio's Olympic Waters

December 16, 2014 11:36 am | by Jenny Barchfield - Associated Press | News | Comments

A drug-resistant "super bacteria" that's normally found in hospitals and is notoriously difficult to treat has been discovered in the waters where Rio de Janeiro's Olympic sailing events will be held, scientists said. Read more...                            

Long noncoding RNAs: A Novel Prognostic Marker In AML

December 16, 2014 11:14 am | by Ohio State University Medical Center | News | Comments

A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) describes a novel marker that might help doctors choose the least toxic, most effective treatment for many older patients with acute myeloid leukemia (AML). Read more...

Antibodies Discovery Could Lead to Universal Dengue Vaccine

December 16, 2014 10:04 am | by University of Melbourne | News | Comments

A major new class of antibodies that can make the four different types of dengue virus (DENV) non-infectious has been discovered by a group of international researchers, including from the University of Melbourne. Read more...                       

Advertisement

NewGen Therapeutics: Activity of Targeted Anti-Cancer Drug

December 16, 2014 9:47 am | News | Comments

NewGen Therapeutics, Inc. announced the publication of preclinical research strongly supporting NT-113, the company's novel irreversible pan-erbB inhibitor (EGFR, HER2 and HER4), as a potential new treatment for glioblastoma multiforme (GBM), the most common and most aggressive malignant primary brain tumor in adults. Read more...

Women in Cell Biology Award Winners Announced at ASCB Meeting

December 15, 2014 4:47 pm | by Stephanie Guzowski, Editor | Articles | Comments

Three exceptional women were given awards for their achievements and contributions to the scientific community at the 2014 ASCB (American Society for Cell Biology) meeting recently held in Philadelphia, Pa. Read more...                               

Going After Colon Cancer With Strep Bacteria

December 15, 2014 2:19 pm | by Skip Derra, Contributing Writer | Articles | Comments

A novel therapeutic to fight colon cancer by using the bacteria primarily responsible for causing strep throat is being explored in the labs of John McCormick of the Schulich School of Medicine & Dentistry at the University of Western Ontario, London, Ontario, Canada. Read more...

Study Shows Potential for Faster Drug Development

December 15, 2014 1:47 pm | News | Comments

A new study demonstrates the ability to conduct robust cardiac safety characterizations several years earlier than current practice. Read more...                    

FDA Approves Drug That Extends Lung Cancer Survival

December 15, 2014 1:37 pm | by University of California, Los Angeles | News | Comments

The FDA approved a new drug to treat non-small-cell lung cancer offering people new hope in fighting the disease. Read more...                       

FDA Approves Drug That Extends Lung Cancer Survival

December 15, 2014 1:36 pm | by University of California, Los Angeles | News | Comments

The FDA approved a new drug to treat non-small-cell lung cancer offering people new hope in fighting the disease. Read more...                       

Scientists Reveal Neurotransmitter Binding-Site Function

December 15, 2014 1:15 pm | by Ellen Goldbaum, University of Buffalo | News | Comments

New research from University at Buffalo scientists will help pharmacologists better understand how drugs work and how to make them more effective. Read more...                 

Medication Being Studied Could Help Afib Patients After Stroke

December 15, 2014 1:03 pm | by University of South Florida | News | Comments

Researchers are studying the effectiveness of a new rapid-onset anticoagulant medication with the standard anticoagulant drug in stroke patients with atrial fibrillation, the most common type of abnormal heart rhythm. Read more...     

Cancer Patients Testing Drugs on Mouse Avatars

December 15, 2014 12:56 pm | by Marilynn Marchione - AP Chief Medical Writer | News | Comments

The idea is to see which drugs might work best on a specific person's specific cancer. Read more...                           

Potential Hepatitis B Cure Enters Clinical Trial

December 15, 2014 8:52 am | News | Comments

A new treatment promoting the cure of chronic hepatitis B is now recruiting patients for clinical trials. Read more....                        

Key Human Gene Modifies Immune Response to Flu Vaccine

December 12, 2014 11:24 am | News | Comments

How much protection the annual flu shot provides depends on how well the vaccine (which is designed based on a "best guess" for next season's flu strain) matches the actually circulating virus. However, it also depends on the strength of the immune response elicited by the vaccine. Read more...

Taming Inflammatory Response in Kidney Dialysis

December 12, 2014 11:02 am | News | Comments

Over the past several years, lead author John Lambris, PhD, the Dr. Ralph and Sallie Weaver Professor of Research Medicine, Perelman School of Medicine at the University of  Pennsylvania, and his colleagues have developed small molecule versions of the drug compstatin, which inhibits a component of the complement immune response called C3. Read more...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading